Oxidative modification of low-density lipoprotein: lipid peroxidation by myeloperoxidase in the presence of nitrite

被引:23
|
作者
Kraemer, T [1 ]
Prakosay, I [1 ]
Date, RA [1 ]
Sies, H [1 ]
Schewe, T [1 ]
机构
[1] Univ Dusseldorf, Inst Biochem & Mol Biol 1, D-40001 Dusseldorf, Germany
关键词
antioxidant; atherosclerosis; cocoa; epicatechin; flavonoids; LDL oxidation; procyanidins;
D O I
10.1515/BC.2004.106
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oxidative modification of lowdensity lipoprotein (LDL) is a pivotal process in early atherogenesis and can be brought about by myeloperoxidase (MPO), which is capable of reacting with nitrite, a NO metabolite. We studied MPOmediated formation of conjugated dienes in isolated human LDL in dependence on the concentrations of nitrite and chloride. This reaction was strongly stimulated by low concentrations (550 muM) of nitrite which corresponds to the reported concentration in the arterial vessel wall. Under these conditions no protein tyrosine nitration occurred; this reaction required much higher nitrite concentrations (100 muM-1 mM). Chloride neither supported lipid peroxidation alone nor was its presence mandatory for the effect of nitrite. We propose a prominent role of lipid peroxidation for the proatherogenic action of the MPO/nitrite system, whereas peroxynitrite may be competent for protein tyrosine nitration of LDL. Monomeric and oligomeric flavan-3-ols present in cocoa products effectively counteracted, at micromolar concentrations, the MPO/nitritemediated lipid peroxidation of LDL. Flavan-3-ols also suppressed protein tyrosine nitration induced by MPO/nitrite or peroxynitrite as well as Cu2+-mediated lipid peroxidation of LDL. This multisite protection by (-)-epicatechin or other flavan-3-ols against proatherogenic modification of LDL may contribute to the purported beneficial effects of dietary flavan-3-ols for the cardiovascular system.
引用
收藏
页码:809 / 818
页数:10
相关论文
共 50 条
  • [21] A ROLE FOR PEROXIDATION IN ENDOTHELIAL CELL-MODIFICATION OF LOW-DENSITY LIPOPROTEIN (LDL)
    STEINBRECHER, UP
    PARTHASARATHY, S
    WITZTUM, JL
    STEINBERG, D
    CLINICAL RESEARCH, 1984, 32 (02): : A409 - A409
  • [22] Glycoxidation and lipid peroxidation of low-density lipoprotein can synergistically enhance atherogenesis
    Sakata, N
    Uesugi, N
    Takebayashi, S
    Nagai, R
    Jono, T
    Horiuchi, S
    Takeya, M
    Itabe, H
    Takano, T
    Myint, T
    Taniguchi, N
    CARDIOVASCULAR RESEARCH, 2001, 49 (02) : 466 - 475
  • [23] Comparison of low-density lipoprotein modification by myeloperoxidase-derived hypochlorous and hypobromous acids
    Carr, AC
    Decker, EA
    Park, YJ
    Frei, B
    FREE RADICAL BIOLOGY AND MEDICINE, 2001, 31 (01) : 62 - 72
  • [24] Modification of low-density lipoprotein by myeloperoxidase-derived oxidants and reagent hypochlorous acid
    Malle, Ernst
    Marsche, Gunther
    Arnhold, Juergen
    Davies, Michael J.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2006, 1761 (04): : 392 - 415
  • [25] TYROSYL RADICAL GENERATED BY MYELOPEROXIDASE INITIATES LOW-DENSITY-LIPOPROTEIN LIPID-PEROXIDATION
    SAVENKOVA, MI
    FRANCIS, GA
    HEINECKE, JW
    CIRCULATION, 1993, 88 (04) : 179 - 179
  • [26] Concentration Polarization of Oxidative Modification of Low-Density Lipoproteins: Its Effect on Oxidative Modification of Low-Density Lipoprotein Uptake and Apoptosis of the Endothelial Cells
    Ding, Zufeng
    Fan, Yubo
    Deng, Xiaoyan
    ASAIO JOURNAL, 2010, 56 (05) : 468 - 474
  • [27] Modulation of Adrenal Aldosterone Release by Oxidative Modification of Low-Density Lipoprotein
    Ansurudeen, Ishrath
    Pietzsch, Jens
    Graessler, Juergen
    Ehrhart-Bornstein, Monika
    Saha, Sarama
    Bornstein, Stefan R.
    Kopprasch, Steffi
    AMERICAN JOURNAL OF HYPERTENSION, 2010, 23 (10) : 1061 - 1068
  • [28] Effects of some flavonoids on the susceptibility of low-density lipoprotein to oxidative modification
    Safari, MR
    Rezaie, M
    Sheikh, N
    INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS, 2003, 40 (05): : 358 - 361
  • [29] Initiation and progression of atherosclerosis - enzymatic or oxidative modification of low-density lipoprotein?
    Torzewski, Michael
    Lackner, Karl J.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2006, 44 (12) : 1389 - 1394
  • [30] THYROXINE INHIBITS OXIDATIVE MODIFICATION OF HUMAN LOW-DENSITY LIPOPROTEIN BETA-LIPOPROTEIN
    KAMANNA, VS
    NEWMAN, HAI
    FELLER, DR
    WITIAK, DT
    FASEB JOURNAL, 1988, 2 (05): : A1218 - A1218